<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "pegaspargase inj VIAL">
<dose><value>2500</value>
<value>1250</value>
<value>1875</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>750 unit/mL</value>
</strength>
<frequency><value>ONCE</value>
</frequency>
<instruction></instruction>
<volume><value>5 mL</value>
</volume>
<units><value>unit/m2</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Acute Lymphoblastic Leukemia. If grade 3 toxicity occurs, reduce dose by 25%. If grade 4 toxicity occurs, reduce dose by 50%</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3327</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary, Health Canada Special Access Programme.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>